- Home
- CCM vs RADX Comparison
CCM vs RADX Comparison
Compare CCM & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- RADX
- Stock Information
- Founded
- CCM 1997
- RADX 2021
- Country
- CCM China
- RADX Australia
- Employees
- CCM N/A
- RADX N/A
- Industry
- CCM Medical/Nursing Services
- RADX
- Sector
- CCM Health Care
- RADX
- Exchange
- CCM Nasdaq
- RADX NYSE
- Market Cap
- CCM 33.3M
- RADX 32.5M
- IPO Year
- CCM 2009
- RADX N/A
- Fundamental
- Price
- CCM $5.68
- RADX $4.17
- Analyst Decision
- CCM
- RADX Strong Buy
- Analyst Count
- CCM 0
- RADX 2
- Target Price
- CCM N/A
- RADX $13.50
- AVG Volume (30 Days)
- CCM 2.3K
- RADX 22.5K
- Earning Date
- CCM 04-25-2025
- RADX 02-26-2025
- Dividend Yield
- CCM N/A
- RADX N/A
- EPS Growth
- CCM N/A
- RADX N/A
- EPS
- CCM N/A
- RADX N/A
- Revenue
- CCM $52,603,198.00
- RADX $204,609.00
- Revenue This Year
- CCM N/A
- RADX N/A
- Revenue Next Year
- CCM N/A
- RADX N/A
- P/E Ratio
- CCM N/A
- RADX N/A
- Revenue Growth
- CCM N/A
- RADX N/A
- 52 Week Low
- CCM $3.80
- RADX $3.50
- 52 Week High
- CCM $10.90
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- CCM 38.23
- RADX N/A
- Support Level
- CCM $5.50
- RADX N/A
- Resistance Level
- CCM $5.95
- RADX N/A
- Average True Range (ATR)
- CCM 0.19
- RADX 0.00
- MACD
- CCM 0.01
- RADX 0.00
- Stochastic Oscillator
- CCM 39.74
- RADX 0.00
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.